Stentra™
Head and Neck Cancer Radiation Therapy (Immobilization)
Key Facts
About Kallisio
Kallisio is a private, commercial-stage medical device company pioneering personalized, oral-cavity-based solutions to enhance treatment accuracy and safety, primarily in oncology. Its core technology platform integrates patient anatomical data with intelligent design software and 3D printing to produce custom-fit medical devices, beginning with the Stentra™ system for head and neck radiation therapy. The company targets the significant clinical need to reduce side effects and improve workflow efficiency in precision oncology, leveraging a team with deep medtech experience and partnerships with leading cancer centers. Kallisio operates on a B2B model, providing devices and digital services to healthcare institutions, and is backed by established reimbursement pathways for its flagship product.
View full company profile